Medilink
Retail · United Kingdom · 501-1,000 Employees
View Company Info for Free
Overview
Headquarters
119 Sidwell St, Exeter, Devon, EX4 6RY, ...Phone Number
+44 800626388Website
www.saltsmedilink.co.ukRevenue
$67.1 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Medilink
Medilink® offers care, choice and convenience when ordering your prescription stoma & continence products. Order online to receive a reliable, free and discreet home delivery service to suit your individual needs.Explore more
Medilink Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Medilink your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Medilink launches new products
Congratulate Masked Content for being promoted to Masked Content at Medilink
Funding: Get notified immidiatlly once Medilink has new funding data
Click to see if Medilink had a recent Job posting/layoffs
Medilink, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Medilink recently announced quarterly report
Check if Medilink has recently received funding, and reach out quickly before it becomes old news!
Check out if Medilink is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Medilink
Compare insights from companies similar to Medilink, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Medilink is experiencing very low activity levels compared to other companies in the Retail sector.
What does this means?
Medilink is drawing exceptional interest within the Retail industry, suggesting notable developments or strong market momentum, learn more about Medilink.
Medilink Tech Stack
A closer look at the technologies used by Medilink
Medilink News & Media
MediLink Announces Global Clinical Trial Collaboration and Supply Agreement on YL201 Combination Therapy
SUZHOU, China, Oct. 8, 2024 /PRNewswire/ -- MediLink Therapeutics (Suzhou) Co., Ltd. ("MediLink"), a clinical-stage biotech company, today announced a global clinical trial collaboration and supply agreement with Amgen Inc. Amgen will lead a global clinical study to evaluate the therapeutic potential of the combination of MediLink's B7-H3-targeting antibody-drug conjugate (ADC) YL201 and Amgen's DLL3- and CD3-targeting bispecific T-cell engager (BiTE®) IMDELLTRA™ in extensive-stage small cell luMediLink presents YL201 (B7H3 ADC) at ESMO 2024, with over 6-months PFS in SCLC, and showing pan-tumor benefits
The first publication of clinical data for YL201, featured in an oral presentation at ESMO 2024. Encouraging antitumor activity of YL201 in multiple solid tumor types, including SCLC, NPC, and wild-type NSCLC, from Phase I escalation and expansion results. In extensive-stage SCLC patients, ORR was 68.1% and mPFS was 6.2 months. SUZHOU, China, Sept. 14, 2024 /PRNewswire/ -- MediLink Therapeutics (MediLink) today presented clinical data for YL201, a novel B7H3-targeting antibody drug conjugate (ADUS FDA puts partial clinical hold on BioNTech's early-stage study of cancer drug
The drug, an antibody-drug conjugate (ADC), was being studied in a trial sponsored by China-based MediLink, in patients with types of non-small cell lung cancer or breast cancer who have received prior forms of treatment. ADCs, often described as "guided-missile" cancer drugs, are designed to target only cancer cells, unlike conventional chemotherapy, potentially reducing damage to normal cells. The U.S. health regulator has shared with MediLink concerns that the drug, BNT326/YL202, may, atMediLink Therapeutics announces a multi-target TMALIN® ADC technology platform license agreement with BioNTech, expanding their global strategic partnership
SUZHOU, China, May 27, 2024 /PRNewswire/ -- MediLink Therapeutics (Suzhou) Co., Ltd. ("MediLink"), a clinical-stage biotech company, today announces a new strategic collaboration with BioNTech SE (Nasdaq: BNTX, "BioNTech"), a next-generation immunotherapy company pioneering novel therapies for cancer and other serious diseases, under which BioNTech will receive an exclusive option to an exclusive global license to apply MediLink's TMALIN® antibody-drug conjugate (ADC) platform, for several novel
Read more news
Top Retail Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Medilink
Sign Up For FreeTo access detailed company insights
Medilink® offers care, choice and convenience when ordering your prescription stoma & continence products. Order online to receive a reliable, free and discreet home delivery service to suit your individual needs.... Read More
